| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Corgenix, Inc. Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights
into a Corgenix, Inc.'s pipeline and investigational products. The report also
provides details on clinical trials covering trial phase, description,
investigator information, primary and secondary end-points and trial results
for products in development.
Scope
• Details of development stage by sector and equipment type.
• Pipeline
products grouped by therapy area, development stage and trial phase.
•
Detailed information on clinical trials covering trial phase, description,
investigator .nformation, primary and secondary end-points and trial
results.
• Trial updates, trial start and end dates, patient numbers and
the trials primary outcome measures, secondary outcome measures.
• Product
updates covering estimated approval dates and estimated launch dates.
•
Descriptions of novel technologies relating to pipeline products of the
company.
• Patents and patent applications covered for the product.
•
News updates on key events relating to the product and its development.
Reasons to buy
• A single source to fulfill competitor information relating to products in
development.
• Identify pipeline products that are potential competitor to
your product lines.
Understand a company's strategic position by accessing
detailed independent intelligence on its product pipeline.
• Access
clinical trial information to map trial results and plan targeted marketing
activities.
• Take corrective measures on your own development programs
and R&D initiatives based on regulatory events of competitor product
pipelines.
• Identification of potential investment opportunities.
•
Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets
you keep track of market potential build for a new product.
Assess a
company's future growth by determining its pipeline depth, for probable
acquisition opportunities.
TABLE OF CONTENTS
1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2
Company Overview 7
2.1 Key Information 7
2.2 Industry Outlook -- In
Vitro Diagnostics 7
3 Major Products and Services 8
3.1 Overview 8
4 Key Employees 9
5 Locations And Subsidiaries 10
5.1 Head Office
10
5.2 Other Locations & Subsidiaries 10
6 Recent Developments 11
6.1 Product News 11
6.1.1 Jul 28, 2008: Corgenix Announces Collaboration
With SpectraCell Laboratories 11
6.1.2 Apr 10, 2008: Corgenix Announces
FDA Clearance For IgG Anti-AtherOx Test Kit 11
6.1.3 Apr 03, 2008:
Corgenix Medical Corporation Signs Collaboration Agreement With Randox
Laboratories To Develop And Market Automated Version Of AspirinWorks Test
11
6.1.4 Mar 18, 2008: Corgenix Acquires Rights To Serum Amyloid
Technology 12
6.1.5 Feb 25, 2008: Corgenix Announces Issuance Of European
Patent For Aspirin Resistance Testing 12
6.1.6 Oct 15, 2007: Corgenix
Announces Initial Results In Development Of New Tests For Viral Infections And
Bioterrorism Threats 12
6.1.7 Jul 30, 2007: Corgenix Submits 510(k) Filing
For IgG Anti-AtherOx Test Kit 12
6.2 Product Approvals 13
6.2.1 Apr
10, 2008: Corgenix Announces FDA Clearance For IgG Anti-AtherOx Test Kit
13
6.3 Clinical Trials 13
6.3.1 Oct 15, 2007: Corgenix Announces
Initial Results In Development Of New Tests For Viral Infections And
Bioterrorism Threats 13
7 Corgenix, Inc. Pipeline Products 14
7.1
Corgenix, Inc. Product Pipeline Analysis 14
7.1.1 Corgenix, Inc. Pipeline
Products By Equipment Type 14
7.1.2 Corgenix, Inc. Pipeline Products By
Development Stage 15
7.1.3 Corgenix, Inc. Pipeline Products By Therapy
Area 15
7.1.4 Corgenix, Inc. Pipeline Products By News Summary 16
7.2
VHF detection test 16
7.2.1 Product Description 16
7.2.2 Product
Status 16
7.2.3 Product Milestone 16
7.3 Serum Amyloid Technology
17
7.3.1 Product Description 17
7.3.2 Product Status 17
7.3.3
Product Milestone 17
7.4 Automated Version of AspirinWorks Test 18
7.4.1 Product Description 18
7.4.2 Product Status 18
7.4.3 Product
Milestone 18
8 Appendix 20
8.1 Methodology 20
8.1.1 Coverage
20
8.1.2 Secondary Research 21
8.1.3 Primary Research 21
8.1.4
Expert Panel Validation 22
8.2 Contact Us 22
8.3 About Global Markets
Direct 22
8.4 Disclaimer 22
1.1 List of Tables
Table 1:
Corgenix, Inc.,Key Facts 7
Table 2: Corgenix, Inc., Key Employees,
9
Table 3: Corgenix, Inc., Other Locations 10
Table 4:
Corgenix, Inc. Pipeline Products by Equipment Type 14
Table 5:
Corgenix, Inc. Pipeline Products By Development Stage 15
Table 6:
Corgenix, Inc. Pipeline Products By Therapy Area 15
Table 7:
Corgenix, Inc. Pipeline Products By News Summaries 16
1.2 List of
Figures
Figure 1: Corgenix, Inc. Pipeline Products By Development
Stage 15
Figure 2: Global Markets Direct Methodology 20
|
